Area:
development of a toolbox of reagents and technologies to translate genome sequence into functional insights
Website:
http://www.genome.gov/12512321
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Christopher P. Austin is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 1991 — 1993 |
Austin, Christopher Perry [⬀] |
K11Activity Code Description:
Undocumented code - click on the grant title for more information. |
Effect of Fgfs On Retinal Development and Pathology @ Harvard University (Medical School)
The fibroblast growth factor family (FGF) of neurotrophic and mitogenic factors has been implicated in ocular development and disease. These factors can act as mitogens for retinal progenitor cells, induce neovascularization, and effect the state of differentiation of the pigmented epithelium. Expression of the messenger RNA encoding these factors and cognate receptors has been demonstrated for several periods during development and in the adult eye. This proposal aims to further define the role(s) of these factors in vivo in eye development; to determine whether they can induce neovascularization when overexpressed; to determine if reduction in expression can block neovascularization; and to determine whether they play a role in postnatal eye growth. FGF genes and the FGF receptor genes will be introduced into developing eyes of rodents and chicks using retrovirus vectors. This has been previously been demonstrated to be a successful way to achieve stable gene expression in ocular tissue in vivo. The various assays and protocols explore different ways to effect levels of expression of the FGF family. If controlling expression levels using gene transfer can be achieved, there is a potential for using this strategy, or a derivative of it, for control of neovascularization in e.g. diabetic retinopathy.
|
0.903 |
| 1994 — 1995 |
Austin, Christopher Perry [⬀] |
K11Activity Code Description:
Undocumented code - click on the grant title for more information. |
Fgfs Effect On Retinal Development and Pathology @ Harvard University (Medical School)
The fibroblast growth factor family (FGF) of neurotrophic and mitogenic factors has been implicated in ocular development and disease. These factors can act as mitogens for retinal progenitor cells, induce neovascularization, and effect the state of differentiation of the pigmented epithelium. Expression of the messenger RNA encoding these factors and cognate receptors has been demonstrated for several periods during development and in the adult eye. This proposal aims to further define the role(s) of these factors in vivo in eye development; to determine whether they can induce neovascularization when overexpressed; to determine if reduction in expression can block neovascularization; and to determine whether they play a role in postnatal eye growth. FGF genes and the FGF receptor genes will be introduced into developing eyes of rodents and chicks using retrovirus vectors. This has been previously been demonstrated to be a successful way to achieve stable gene expression in ocular tissue in vivo. The various assays and protocols explore different ways to effect levels of expression of the FGF family. If controlling expression levels using gene transfer can be achieved, there is a potential for using this strategy, or a derivative of it, for control of neovascularization in e.g. diabetic retinopathy.
|
0.903 |